New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
15:10 EDTEWEdwards Lifesciences approval for Sapien Xt not far behind, says Jefferies
Jefferies said Edwards Lifesciences (EW) should receive FDA approval for Sapien XT shortly following the early than expected approval of Medtronic's (MDT) TAVR system. The firm reiterates its Buy rating and $72 price target.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for EW

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use